Search results
Results From The WOW.Com Content Network
Nov. 12—If you shop online or use the smartphone app for Hannaford Supermarkets, you've been shut out since late last week because of cybersecurity problems. No rewards, no digital coupons, no ...
Pfizer also said a Phase 2 trial of its second-generation mRNA flu vaccine candidate showed that the formulation elicited robust influenza A and B responses, with no safety issues reported.
Mar. 2—Hannaford Supermarkets on Tuesday became the latest retailer to offer COVID-19 vaccines, with the grocery store chain's pharmacies opening up shots for those eligible at 35 locations ...
A phase 3 clinical trial with 25,798 participants found that the vaccine is 64% (95% CI, 29 – 82%) effective against asymptomatic cases, 78% (65 – 86%) effective against symptomatic disease, 93% (57 – 100%) effective against severe disease, and 65% (33 – 83%) effective against the Delta variant.
Hannaford is an American supermarket chain based in Scarborough, Maine. [2] Founded in Portland, Maine , in 1883, Hannaford operates stores in New England and New York . The chain is part of the Ahold Delhaize group based in the Netherlands , and is a sister company to formerly competing New England supermarket chain Stop & Shop .
The COVID-19 vaccination campaign in the United States is an ongoing mass immunization campaign for the COVID-19 pandemic in the United States.The Food and Drug Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, [7] and mass vaccinations began four days later.
The updated COVID-19 vaccine is now available. Infectious disease doctors recommend being smart about the timing of your shot. You can expect similar side effects to the previous vaccines if you ...
In December 2021, Medicago announced submission of the Phase III results to Health Canada. [22] In February 2022, Health Canada approved the use of CoVLP for adults aged 18–64 in Canada. [3] The CoVLP vaccine was sold under the brand name Covifenz. [23] On March 31, 2023, Medicago cancelled their authorization to manufacture Covifenz vaccine ...